| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Director
2 companies
Bentsur Ron serves as a Chairman &CEO at NVCT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 78 buys and 28 sells. Those positions are worth an estimated $82.7M at current prices.
Historically, Bentsur Ron's trades have earned a middling insider score of 64/100 across 73 rated trades. Over a 12-month horizon, 52.8% of those trades were profitable, with an average 12-month return of +6.6%.
The biggest single holding is NVCT (~$81.8M) as Chairman &CEO. Net of sales, the recent Form 4 record there shows accumulation of 392,965 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 12,500 | $20.00 | $250,000.00 | +0.3% | - | - | |
| Nov 5, 2025 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 5,000 | $5.72 | $28,600.00 | +0.1% | +50.1% | - | |
| Dec 24, 2024 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 4,500 | $4.65 | $20,925.00 | +0.1% | +111.0% | +65.8% | |
| Nov 15, 2024 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 20,000 | $4.92 | $98,400.00 | +0.6% | +40.4% | +21.6% | |
| May 14, 2024 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,940 | $6.74 | $13,075.60 | - | -6.9% | +36.5% | |
| May 10, 2024 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 2,000 | $6.40 | $12,800.00 | - | +6.9% | +40.5% | |
| Mar 18, 2024 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 5,000 | $10.29 | $51,450.00 | +0.2% | -34.4% | -9.7% | |
| Oct 10, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 640 | $11.08 | $7,091.20 | - | -5.7% | -43.5% | |
| Oct 9, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,080 | $11.21 | $12,105.20 | - | -7.0% | -44.7% | |
| Oct 5, 2023 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 3,220 | $11.01 | $35,455.00 | - | -23.8% | -43.9% |